Browse Category

Earnings Reports News 6 November 2025

Fastly (FSLY) Soars After Record Q3: Security Revenue +30%, Guidance Raised; Shares Jump ~26% on Nov. 6, 2025

Fastly (FSLY) Soars After Record Q3: Security Revenue +30%, Guidance Raised; Shares Jump ~26% on Nov. 6, 2025

Fastly, Inc. (FSLY) ripped higher today after posting record third‑quarter results and lifting guidance. By mid‑afternoon (UTC), the stock traded around $10.20, up roughly 26% intraday from Wednesday’s close, as investors digested stronger‑than‑expected revenue, expanding margins, and brisk growth in Fastly’s security portfolio. MarketScreener Key takeaways What happened today Fastly shares extended gains after the company’s Q3 results showed broad‑based improvement and a meaningfully higher outlook. Pre‑market coverage pointed to a double‑digit jump after the release, and shares remained sharply higher through the session, buoyed by analyst target hikes and a risk‑on tape for software. MarketScreener+2XTB.com+2 “We delivered record revenue,
Salesforce (CRM) Tumbles ~6%: Wall Street Targets Diverge, Options Flow Turns Mixed, and Q3 FY26 Results Land on Dec. 3

Salesforce (CRM) Tumbles ~6%: Wall Street Targets Diverge, Options Flow Turns Mixed, and Q3 FY26 Results Land on Dec. 3

What happened today Salesforce shares fell roughly 6–7% intraday on Thursday, Nov. 6, extending this week’s softness across enterprise software. The drop was hefty enough to rank among the largest decliners in the Dow, alongside Amazon, contributing significantly to the index’s pullback. MarketWatch Traders point to a light news tape ahead of earnings and continued sector rotation as key drivers. The next hard data point arrives Dec. 3 when Salesforce posts Q3 FY26 results after the close and fields investor questions on the 5:00 p.m. ET call. investor.salesforce.com+1 What Wall Street is saying right now Freshly compiled Street data show
Cummins (CMI) Q3 2025: Revenue $8.32B, Adjusted EPS $5.59; Dividend Lifted to $2.00 as Data‑Center Power Drives Beat and Accelera Faces Strategic Review

Cummins (CMI) Q3 2025: Revenue $8.32B, Adjusted EPS $5.59; Dividend Lifted to $2.00 as Data‑Center Power Drives Beat and Accelera Faces Strategic Review

Cummins Inc. (NYSE: CMI) delivered a stronger‑than‑expected third quarter, powered by surging demand for data‑center backup generation and solid service activity, even as North American truck markets softened. The company also raised its quarterly dividend and said it is conducting a strategic review of its electrolyzer business within the Accelera unit following non‑cash charges this quarter. Reuters+1 Market reaction As of 15:03 UTC today, CMI shares were up about 7.6% at $472.49, after earlier trading as high as $481.76. The rally followed the top‑ and adjusted bottom‑line beats and the dividend increase. (See live chart above.) By the numbers: Q3
Krispy Kreme (DNUT) Q3 2025: Adjusted EPS Turns Positive, Free Cash Flow Returns as Turnaround Gains Traction — Nov. 6, 2025

Krispy Kreme (DNUT) Q3 2025: Adjusted EPS Turns Positive, Free Cash Flow Returns as Turnaround Gains Traction — Nov. 6, 2025

Krispy Kreme, Inc. (NASDAQ: DNUT) reported third‑quarter 2025 results before the bell, showing early progress on its turnaround: revenue softened year over year, but margins, cash generation and adjusted profitability improved. Shares jumped in early trading after the company posted a surprise positive adjusted EPS and reiterated expectations for stronger cash flow into year‑end. investors.krispykreme.com+1 Key numbers at a glance (Q3 FY2025) Context on EPS figures: The Associated Press notes a $19.4M net loss attributable to shareholders (–$0.11 per share GAAP) and $0.01 in adjusted earnings per share, aligning with the company’s non‑GAAP presentation. Yahoo Finance Why the stock is
Vistra (VST) Q3 2025: $652M Profit, 2026 EBITDA Outlook Raised to $6.8–$7.6B; Board Adds $1B Buyback

Vistra (VST) Q3 2025: $652M Profit, 2026 EBITDA Outlook Raised to $6.8–$7.6B; Board Adds $1B Buyback

What Vistra reported today Vistra posted third‑quarter 2025 GAAP net income of $652 million and Ongoing Operations Adjusted EBITDA of $1.581 billion. Management said the year‑over‑year decline in GAAP profit primarily reflects lower unrealized mark‑to‑market gains on hedging positions and the Martin Lake Unit 1 outage, partially offset by recognition of nuclear production tax credit revenue and firmer capacity prices. PR Newswire Top line performance came in at $4.97 billion, about 21% lower than the prior year’s quarter. Investors Guidance: a bigger 2026, tighter 2025 On the call and in media briefings, Vistra linked the stronger 2026 outlook to expanding
Stagwell (STGW) Soars After Q3 Beat and Palantir AI Partnership; 2025 Outlook Calls for ~8% Net Revenue Growth (Nov. 6, 2025)

Stagwell (STGW) Soars After Q3 Beat and Palantir AI Partnership; 2025 Outlook Calls for ~8% Net Revenue Growth (Nov. 6, 2025)

What’s new today Earnings: Stagwell Inc. (NASDAQ: STGW) reported third‑quarter revenue of $743 million, GAAP EPS of $0.09, and adjusted EPS of $0.24. Management highlighted double‑digit “ex‑advocacy” momentum, with net revenue ex‑advocacy up 10% to $578 million, and adjusted EBITDA of $115 million (19% margin on net revenue). The company also pointed to $122 million in net new business for the quarter and a $100 million year‑to‑date improvement in operating cash flow versus last year. PR Newswire Independent wire coverage from the Associated Press echoed the headline figures and noted the full‑year adjusted EPS range of $0.75–$0.88. Times Union Street
Iovance Biotherapeutics (IOVA) Q3 2025: Revenue Climbs ~13% to ~$68M; Gross Margin Hits 43%, Guidance Reaffirmed — November 6, 2025

Iovance Biotherapeutics (IOVA) Q3 2025: Revenue Climbs ~13% to ~$68M; Gross Margin Hits 43%, Guidance Reaffirmed — November 6, 2025

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) reported third‑quarter 2025 results this morning (Nov. 6), highlighting sequential revenue growth, materially higher gross margins, and steady commercial momentum for its tumor‑infiltrating lymphocyte (TIL) therapy Amtagvi. Management also reaffirmed full‑year revenue guidance and flagged pipeline milestones led by encouraging lung‑cancer data for lifileucel. GlobeNewswire What Iovance announced (Nov. 6, 2025) Revenue, margin, and guidance. Total product revenue grew to ~$68M in Q3 (Amtagvi ~$58M; Proleukin ~$10M). Gross margin expanded to 43% on improved execution and early cost‑savings. Management reaffirmed $250–$300M in 2025 revenue. GlobeNewswire Earnings snapshot. An AP/Automated Insights brief noted a net loss
Novavax (NVAX) Raises 2025 Revenue Outlook After Q3 Beat; Sanofi Milestones Drive Guidance — November 6, 2025

Novavax (NVAX) Raises 2025 Revenue Outlook After Q3 Beat; Sanofi Milestones Drive Guidance — November 6, 2025

What happened today Novavax, Inc. (NASDAQ: NVAX) reported Q3 2025 results and raised its full‑year adjusted revenue framework to $1.04–$1.06 billion (from $1.00–$1.05 billion). Management cited momentum from licensing, supply, and milestone revenue—while excluding Sanofi‑led sales and royalties from the outlook. The company also reaffirmed 2025 operating‑expense guidance. ir.novavax.com Revenue for the quarter came in at $70 million, above Wall Street expectations, while the GAAP net loss widened to $202 million year‑over‑year, reflecting $126 million in non‑cash charges, including $97 million related to a previously announced Maryland facility consolidation. Reuters On a per‑share basis, Novavax posted a GAAP loss of
Fortinet (FTNT) slips on soft Q4 outlook after Q3 beat; price targets trimmed as company unveils “Secure AI Data Center” — Nov. 6, 2025

Fortinet (FTNT) slips on soft Q4 outlook after Q3 beat; price targets trimmed as company unveils “Secure AI Data Center” — Nov. 6, 2025

Earnings snapshot: strong quarter, but guidance cools sentiment What happened: Fortinet’s September‑quarter (Q3 FY25) revenue rose ~14% to ~$1.72B with adjusted EPS at $0.74 (vs. ~$0.63 expected). Billings—a forward demand proxy—also climbed ~14% to ~$1.81B. After the report, investors focused on the softer Q4 guide, which ran a touch below consensus and drove the shares lower in late trading. Investors Profitability: Management cited a record Q3 non‑GAAP operating margin of ~36.9% (GAAP operating margin also a third‑quarter record, per the release). That efficiency was a bright spot despite the cautious near‑term revenue view. Investing.com+1 Q4 & FY25 outlook: Fortinet now
AppLovin (APP) soars ~7% after blowout Q3 2025: revenue up 68%, buyback boosted by $3.2B, and Wedbush lifts price target to $800

AppLovin (APP) soars ~7% after blowout Q3 2025: revenue up 68%, buyback boosted by $3.2B, and Wedbush lifts price target to $800

AppLovin Corporation (NASDAQ: APP) is rallying today after reporting another set of blockbuster results and raising its buyback firepower. Shares were up roughly 7%–8% in Thursday trading as investors digested the company’s stronger‑than‑expected Q3 print and upbeat Q4 outlook, while sell‑side analysts raised targets. Barron’s+1 Key takeaways What happened in Q3 (ended Sept. 30, 2025) AppLovin’s top and bottom lines accelerated again in Q3: Management also highlighted $1.05B in operating cash flow and free cash flow during the quarter, underpinned by continued scale in its software and AI solutions for advertisers. Q4 Investor Relations Capital returns: buyback gets much bigger
DoorDash (DASH) plunges as 2026 spending plan eclipses Q3 beat — What to know today (Nov 6, 2025)

DoorDash (DASH) plunges as 2026 spending plan eclipses Q3 beat — What to know today (Nov 6, 2025)

DoorDash, Inc. (NASDAQ: DASH) is under pressure today after the delivery platform beat Q3 revenue and order-growth expectations but told investors it will spend “several hundred million dollars more” in 2026 to accelerate a new global tech platform and other initiatives. Shares fell sharply in after‑hours trading last night and were down again in early trading today as Wall Street digested the outlook. Financial Times+1 By the numbers (Q3 2025, quarter ended Sept. 30) Earnings vs. expectations: DoorDash reported $0.55 EPS, missing Street estimates (variously reported around $0.67–$0.69). Total costs and expenses rose ~23% to $3.19B, pressuring margins. Reuters+1 Why
D‑Wave Quantum (QBTS) Q3 2025: Revenue Doubles to $3.7M, Record $836M Cash, Bookings Accelerate — What It Means for the Stock Today

D‑Wave Quantum (QBTS) Q3 2025: Revenue Doubles to $3.7M, Record $836M Cash, Bookings Accelerate — What It Means for the Stock Today

D‑Wave Quantum Inc. (NYSE: QBTS) reported third‑quarter fiscal 2025 results before the open today, delivering 100% year‑over‑year revenue growth to $3.7 million and a sharp sequential uptick in customer bookings to $2.4 million. Shares were recently around $31 intraday, modestly higher following the print. The company also ended the quarter with a record $836.2 million cash balance, while GAAP net loss widened to $140.0 million—driven primarily by non‑cash warrant remeasurement charges. Business Wire Key numbers at a glance (Q3 FY25) Why GAAP loss widened while cash hit a record D‑Wave’s $140.0M GAAP net loss reflects $121.9M in non‑cash, non‑operating charges
1 21 22 23 24 25 48
Go toTop